Quince Therapeutics, Inc.
Quince Therapeutics, Inc. (QNCX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 47 transactions totaling $1.2M, demonstrating a bullish sentiment with $896.7K in net insider flow. The most recent transaction on Jan 23, 2026 involved a transaction of 365,000 shares valued at $0.
QNCX Insider Activity Summary
Who Is Buying QNCX Stock?
No significant insider buying has been recorded for QNCX in the recent period.
Who Is Selling QNCX Stock?
No significant insider selling has been recorded for QNCX in the recent period.
Is Quince Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for QNCX is bullish with an Insider Alignment Score of 86/100 and a net flow of $896.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
QNCX Frequently Asked Questions
Understanding QNCX Insider Activity
Insider trading at Quince Therapeutics, Inc. (QNCX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading QNCX stock, having executed 47 transactions in the past 90 days. The most active insider is David Lamond (Executive), who has made 16 transactions totaling $601.5K.
Related Tools
Track Quince Therapeutics, Inc. Insider Activity
Get notified when executives and directors at QNCX file new Form 4 transactions